Atrial Fibrillation

Emory's Arrhythmia treatment program is one of the most comprehensive and innovative clinics for heart rhythm disorders in the country. Our electrophysiologists rank among the world's leaders in cardiac resynchronization therapy (CRT) and have performed more cardiac ablation procedures than anyone in the southeast.

Emory's electrophysiologists have been pioneers in shaping arrhythmia treatment options for patients with arrhythmias, such as atrial fibrillation, as well as for those with congestive heart disease. As primary and principal investigators for many national clinical trials, Emory has participated in numerous atrial fibrillation (A-fib, AF) and atrial flutter (a-flutter) studies with multiple catheters and energy sources. We are the only center in Georgia participating in a trial that provides alternatives to blood thinners to prevent stroke in patients with A-fib. We also have ongoing clinical trials of new pacemakers, defibrillators, ablation catheters, as well as new ways to use existing devices to help patients.

Emory’s specialized electrophysiology (EP) labs host state-of-the-art equipment, including computerized three-dimensional mapping systems to assist ablation of complex arrhythmias, and an excimer laser system to perform pacemaker and defibrillator lead extractions.

Patients with devices, whether implanted by Emory’s electrophysiologists or elsewhere, have access to Emory’s comprehensive follow-up care. Patients benefit from remote monitoring, quarterly A - Fib support groups and 24 hour ICD and Pacemaker monitoring services.  Inpatient telemetry and coronary care units, as well as outpatient care and educational support of patients with pacemakers and implantable cardiac devices (ICDs), complete Emory’s comprehensive range of arrhythmia treatments and services.

Emory offers arrhythmia screening, treatment and heart rhythm management services at locations across Atlanta.